February 2026
The global anti-epileptic drugs for pediatrics market size is estimated to hit around USD 3.25 billion by 2035 increasing from USD 1.50 billion in 2025, with a CAGR of 8.04%.
July 2026
The global generic drugs market size is estimated at USD 491.67 billion in 2026 and is projected to reach USD 762.48 billion by 2035 at a 5% CAGR, driven by rising demand for affordable medicines and patent-expired drugs.
February 2026
The global performance enhancing drugs market size was evaluated at USD 436.07 million in 2025 and is predicted to hit around USD 892.09 million by 2035, growing at a CAGR of 7.42%.
August 2026
The asthma and COPD drugs market size reached USD 46.93 billion in 2026, with leading asthma and COPD drugs market companies including AstraZeneca, GlaxoSmithKline (GSK), Novartis.
August 2026
The genitourinary drugs market size was USD 30.37 billion in 2026, with leading genitourinary drugs market players including Pfizer inc, johnson & johnson, bayer ag, Sanofi.
August 2026
The pulmonary alveolar proteinosis (PAP) drugs market reached USD 859.05Â million in 2026, with key pulmonary alveolar proteinosis (PAP) drugs market companies including Savara, Inc., Partner Therapeutics, Inc., Nobelpharma Co., Ltd. Amgen Inc
August 2026
The global head and neck cancer drugs market size surpassed USD 18.78 billion in 2025 and is projected to hit around USD 36.48 billion by 2035 with a CAGR of 6.87%.
July 2026
The global over the counter (OTC) drugs market size is expected to increase from USD 135.25 billion in 2025 and is expected to hit USD 256.87 billion by 2035, growing at a CAGR of 6.62%
July 2026
The global immunotherapy drugs market size was valued at USD 318.83 billion in 2025 and is projected to hit around USD 1,607.94 billion by 2035, with a solid CAGR of 17.56%.
July 2026
The lyophilized injectable drugs market size was valued at USD 397.17 billion in 2025 and is expected to attain around USD 1,516.32 billion by 2035, with a CAGR of 14.34%.
July 2026
The global oxycodone drugs market size was valued at USD 7.06 billion in 2025 and is projected to reach around USD 12.10 billion by 2035 with a CAGR of 5.54%.
April 2026
The ovarian cancer drugs market reached USD 4.09 billion in 2025, with prominent companies such as AstraZeneca plc (UK), F. Hoffmann-La Roche Ltd. (Switzerland), GlaxoSmithKline plc (GSK) (UK), AbbVie Inc. (USA), Merck & Co., Inc. (USA) leading the ovarian cancer drugs market.
August 2025
The global deoxycholic acid obesity drugs market size is estimated to hit around USD 1,830.89 million by 2034 increasing from USD 486.14 million in 2024, with a CAGR of 14.18%.
July 2025
The global atrial fibrillation drugs market size was evaluated at USD 15.59 billion in 2024 and is projected to surpass around USD 20.99 billion by 2034, with a CAGR of 3.02%.
July 2025
The inhalation and nasal spray generic drugs market size is projected to hit around USD 54.44 billion by 2034 from USD 23.06 billion in 2024, with a CAGR of 8.97%.
July 2025
The oral transmucosal drugs market size was valued at USD 36.72 billion in 2024 and is projected to attain around USD 70.37 billion by 2034 with a CAGR of 6.72%.
July 2025
The global fibrate drugs market size was valued at USD 3.42 billion in 2024 and is projected to attain around USD 5.67 billion by 2034 with a CAGR of 5.19%.
July 2025
The global antiparasitic drugs market size was estimated at USD 19.44 billion in 2024 and is projected to surge to approximately USD 31.85 billion by 2034, with a CAGR of 5.06%.
June 2025
The global topical drugs CDMO market size was exhibited at USD 46.62 billion in 2024 and is predicted to surpass around USD 136.39 billion by 2034, with a CAGR of 11.33%.
July 2025
The global acute migraine treatment market size was valued at USD 3.46 billion in 2024 and is expected to surge around USD 10.08 billion by 2034 with a CAGR of 11.30%.
August 2026
The bioinformatics market size reached USD 20.99 billion in 2026, with leading bioinformatics market companies including Thermo Fisher Scientific, Inc., Eurofins Scientific, Illumina, Inc.
August 2026
The antibody production market size was estimated at USD 28.04 billion in 2025 and it is expected to surpass USD 93.76 billion by 2035 with a CAGR of 12.83%.
August 2026
The AI for energy optimization software market size reached USD 4.92 billion in 2026, with leading AI for energy optimization software market companies including Siemens, Honeywell, and C3.ai.
August 2026
The high-performance liquid chromatography market size is expected to hit around USD 9.26 billion by 2035 from USD 5.65 billion in 2025 with a CAGR of 5.06%.
August 2026
By Payal Rabde - Aug 2026 - the AI agents for clinical documentation market was valued at USD 1.45 billion in 2025, expanding at a CAGR of 34.15% by 2035.
August 2026
The global materials informatics market size is calculated at USD 208.41 million in 2025 and expected to hit nearly USD 1,314.25 million by 2035, expanding at a strong CAGR of 20.22% from 2026 to 2035.
August 2026
The high performance computing market size is valued at USD 59.85 billion in 2025 and is expected to hit around USD 141.62 billion by 2035, with a CAGR of 9.8%.
August 2026
The global waste management market size is valued at USD 1.37 trillion in 2026 and is expected to hit around USD 2.44 trillion by 2035, growing at a CAGR of 6.66%, driven by rising recycling initiatives and sustainable waste disposal demand.
August 2026
The India laboratory informatics market size was estimated at USD 160 million in 2025 and is projected to be worth around USD 241.43 million by 2035, growing at a CAGR of 4.20%.
August 2026
The global healthcare information systems market size is projected to hit around USD 1,956.49 billion by 2035 from USD 588.39 billion in 2025 with a CAGR of 12.77%.
+1 650 460 3308
+61 485 981 310 +91 87933 22019
sales@precedenceresearch.com